$LPATH INC(LPTN)$ 好消息Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD (Nexus)
This study has been completed.
Sponsor:
Lpath, Inc.
Information provided by (Responsible Party):
Lpath, Inc.
ClinicalTrials.gov Identifier:
NCT01414153
First received: August 9, 2011
Last updated: September 15, 2015
Last verified: September 2015
History of Changes
新药被批准l. [赚大了][赚大了]
iPhone转发:0回复:13喜欢:0

全部评论

只为交易2015-09-18 13:36

我只研究美股

风亦笑我痴痴2015-09-18 13:36

好,兄弟a股没有么?

只为交易2015-09-18 13:35

建议你先建30%的仓。

只为交易2015-09-18 13:29

网页链接这个是新药测试完成信息看看吧

风亦笑我痴痴2015-09-18 13:26

└(^O^)┘好